Immunomodulatory Effects of New Phenanthrene Derivatives from Dendrobium crumenatum

Virunh Kongkatitham,Adeline Dehlinger,Meng Wang,Preeyaporn Poldorn,Carl Weidinger,Marilena Letizia,Chatchai Chaotham,Carolin Otto,Klemens Ruprecht,Friedemann Paul,Thanyada Rungrotmongkol,Kittisak Likhitwitayawuid,Boonchoo Sritularak,Chotima Böttcher
DOI: https://doi.org/10.1021/acs.jnatprod.3c00107
IF: 5.1
2023-05-04
Journal of Natural Products
Abstract:Three new phenanthrene derivatives (<b>1</b>, <b>2</b>, <b>4</b>), one new fluorenone (<b>3</b>), and four known compounds (<b>5</b>-<b>8</b>) were isolated from the ethyl acetate extract of <i>Dendrobium crumenatum</i> Sw. stems using column chromatography. The chemical structures were elucidated by analysis of spectroscopic data. The absolute configuration of <b>4</b> was determined by electronic circular dichroism calculation. We also evaluated the immunomodulatory effects of compounds isolated from <i>D. crumenatum</i> in human peripheral blood mononuclear cells from healthy individuals and those from patients with multiple sclerosis in vitro. Dendrocrumenol B (<b>2</b>) and dendrocrumenol D (<b>4</b>) showed strong immunomodulatory effects on both CD3<sup>+</sup> T cells and CD14<sup>+</sup> monocytes. Compounds <b>2</b> and <b>4</b> could reduce IL-2 and TNF production in T cells and monocytes that were treated with phorbol-12-myristate-13-acetate and ionomycin (PMA/Iono). Deep immune profiling using high-dimensional single-cell mass cytometry could confirm immunomodulatory effects of <b>4</b>, quantified by the reduction of activated T cell population under PMA/Iono stimulation, in comparison to the stimulated T cells without treatment.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?